| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.086 | 0.07 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.074 | 0.07 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.07 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.07 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.07 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.092 | 0.07 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.08 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | -0.086 | 0.08 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.08 |